324 related articles for article (PubMed ID: 28471268)
1. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study.
Brandt F; Thvilum M; Almind D; Christensen K; Green A; Hegedüs L; Brix TH
Thyroid; 2013 Apr; 23(4):408-13. PubMed ID: 23253072
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
[TBL] [Abstract][Full Text] [Related]
4. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
5. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts.
Folkestad L; Brandt F; Lillevang-Johansen M; Brix TH; Hegedüs L
Thyroid; 2020 May; 30(5):672-680. PubMed ID: 31984866
[No Abstract] [Full Text] [Related]
6. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
7. Familial risks for hospitalized Graves' disease and goiter.
Hemminki K; Shu X; Li X; Ji J; Sundquist K; Sundquist J
Eur J Endocrinol; 2009 Oct; 161(4):623-9. PubMed ID: 19661127
[TBL] [Abstract][Full Text] [Related]
8. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
[TBL] [Abstract][Full Text] [Related]
9. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
10. Total thyroidectomy: is morbidity higher for Graves' disease than nontoxic goiter?
Welch KC; McHenry CR
J Surg Res; 2011 Sep; 170(1):96-9. PubMed ID: 21550063
[TBL] [Abstract][Full Text] [Related]
11. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of hyperthyroidism.
Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327
[TBL] [Abstract][Full Text] [Related]
16. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
Bürgi U; Gerber H; Peter HJ
Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
18. Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism.
Ohrling H; Törring O; Yin L; Iliadou AN; Tullgren O; Abraham-Nordling M; Wallin G; Hall P; Lönn S
J Clin Endocrinol Metab; 2014 Sep; 99(9):3217-23. PubMed ID: 24878049
[TBL] [Abstract][Full Text] [Related]
19. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
Schicha H; Dietlein M
Nuklearmedizin; 2002 Apr; 41(2):63-70. PubMed ID: 11989300
[TBL] [Abstract][Full Text] [Related]
20. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
